Physiogenex will be attending Biomed Israël 2023 annual meeting in Tel Aviv, May 16 – May 18 and will be hosted by Business France French HealthCare at booth #60.
Our Director of Research and Business Development at Physiogenex, Dr. François Briand will be attending Biomed to present our preclinical models and CRO services during the event.
Visit booth#60 and reach out to François Briand during Biomed Israel to learn how Physiogenex will help you driving your preclinical drug development to success.
Feel free to contact us if you wish to set-up an appointment with Dr. Briand or discuss your drug development projects with us.
Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.
We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis), cardiovascular and renal complications.